CAS No.63659-19-8,Betaxolol hydrochloride Suppliers

Products Categories

Pharmaceutical (77)
Others (34)
Organic Chemicals (23)
Reagent (2)

Basic Information

Molecular Structure:
CAS No.:	63659-19-8
Name:	Betaxolol hydrochloride
Article Data:	3

Formula:	C₁₈H₂₉NO₃^.HCl
Molecular Weight:	343.894
Synonyms:	2-Propanol,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-,hydrochloride (9CI);Betapress;Betoptic;Betoptima;Kerlone;SL 75212;SLD 212;Betaxolol hydrochloride;
EINECS:	264-384-3
Melting Point:	116°
Boiling Point:	448 °C at 760 mmHg
Flash Point:	224.7 °C
Solubility:	soluble in water
Appearance:	white solid
Hazard Symbols:	Xn
Risk Codes:	22
PSA:	50.72000
LogP:	3.58630

Total:108 Page 1 of 3 1 2 3 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 63659-19-8

Specification

The 2-Propanol,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-,hydrochloride (1:1), with the CAS registry number 63659-19-8, is also known as Betaxolol hydrochloride. It belongs to the product categories of Cardiovascular; Adrenoceptor. Its EINECS number is 264-384-3. This chemical's molecular formula is C₁₈H₂₉NO₃^.HCl and molecular weight is 343.89. What's more, its systematic name is 1-{4-[2-(Cyclopropylmethoxy)ethyl]phenoxy}-3-(isopropylamino)-2-propanol hydrochloride (1:1). Its classification codes are: (1)Anti-anginal; (2)Antihypertensive; (3)Drug / Therapeutic Agent; (4)Reproductive Effect. This chemical should be sealed and stored in a cool and dry place. Moreover, it should be protected from oxides. It is harmful if swallowed. This substance is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma. Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers. It also shows greater affininty for beta1 receptors than metoprolol. In addition to its effect on the heart, it reduces the pressure within the eye.

Physical properties of 2-Propanol,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-,hydrochloride (1:1) are: (1)ACD/LogP: 2.687; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.33; (4)ACD/LogD (pH 7.4): 0.84; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 9.75; (9)#H bond acceptors: 4; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 12; (12)Polar Surface Area: 30.93 Å²; (13)Flash Point: 224.7 °C; (14)Enthalpy of Vaporization: 74.44 kJ/mol; (15)Boiling Point: 448 °C at 760 mmHg; (16)Vapour Pressure: 8.26E-09 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: Cl.O(CCc1ccc(OCC(O)CNC(C)C)cc1)CC2CC2
(2)Std. InChI: InChI=1S/C18H29NO3.ClH/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16;/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3;1H
(3)Std. InChIKey: CHDPSNLJFOQTRK-UHFFFAOYSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LD50	oral	30mg/kg (30mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 25, Pg. 815, 1994.
mouse	LD50	intravenous	37mg/kg (37mg/kg)		United States Patent Document. Vol. #4252984,
mouse	LD50	oral	48mg/kg (48mg/kg)	BEHAVIORAL: TREMOR BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	L.E.R.S. Monograph Series. Laboratories d'Etudes et de Recherches Synthelabo Monograph Series Vol. 1, Pg. 43, 1983.
mouse	LD50	subcutaneous	332mg/kg (332mg/kg)	LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD SKIN AND APPENDAGES (SKIN): HAIR: OTHER	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18(Suppl,
rat	LD50	intravenous	27400ug/kg (27.4mg/kg)	BEHAVIORAL: TREMOR SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18(Suppl,
rat	LD50	oral	998mg/kg (998mg/kg)		Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18(Suppl,
rat	LD50	oral	998mg/kg (998mg/kg)	BEHAVIORAL: ATAXIA BEHAVIORAL: TREMOR	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18(Suppl,
rat	LD50	subcutaneous	389mg/kg (389mg/kg)	LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD SKIN AND APPENDAGES (SKIN): HAIR: OTHER	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18(Suppl,